New cancer clinical trial: Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Published on: December 28, 2017 at 10:00AM
Conditions:   Breast Cancer Female;   Breast Cancer, Male;   Breast Cancer Stage I;   Breast Cancer Stage II;   Breast Cancer Stage III;   Residual Disease;   HER2-positive Breast Cancer;   HER2 Positive Breast Carcinoma
Interventions:   Biological: DC1 Vaccine;   Biological: WOKVAC Vaccine
Sponsor:   H. Lee Moffitt Cancer Center and Research Institute
Not yet recruiting
http://ift.tt/2CfFdDX